These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Prevention with vasoactive drugs]. Motz W; Vogt M; Scheler S; Schwartzkopff BE; Kelm M; Strauer BE Z Kardiol; 1992; 81 Suppl 4():199-204. PubMed ID: 1290299 [TBL] [Abstract][Full Text] [Related]
6. [Benefits and risks of hypertension therapy from the cardiac viewpoint]. Motz W; Strauer BE Z Kardiol; 1994 Mar; 83(3):179-87. PubMed ID: 8178541 [TBL] [Abstract][Full Text] [Related]
7. [Long-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension and microvascular angina]. Vogt M; Motz W; Strauer BE Arzneimittelforschung; 1994 Dec; 44(12):1321-8. PubMed ID: 7848351 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of myocardial and coronary effects of arterial hypertension]. Strauer BE; Motz W; Vogt M Z Kardiol; 1989; 78 Suppl 7():231-8. PubMed ID: 2533767 [TBL] [Abstract][Full Text] [Related]
9. [Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy]. Agabiti-Rosei E Drugs; 2003; 63 Spec No 1():19-29. PubMed ID: 12708883 [TBL] [Abstract][Full Text] [Related]
10. The concept of coronary flow reserve. Strauer BE J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S67-80. PubMed ID: 1381797 [TBL] [Abstract][Full Text] [Related]
11. Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension. Clozel JP; Kuhn H; Hefti F J Hypertens; 1989 Apr; 7(4):267-75. PubMed ID: 2524524 [TBL] [Abstract][Full Text] [Related]
12. Coronary vascular changes in the progression and regression of hypertensive heart disease. Strauer BE; Schwartzkopff B; Motz W; Vogt M J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S20-7. PubMed ID: 1720480 [TBL] [Abstract][Full Text] [Related]
13. [Coronary reserve of the hypertensive heart: relationship to left ventricular hypertrophy]. Fukai M; Ishihara T; Nakano T; Yamada Y; Tamoto S; Takada K; Ashida H; Fujiwara M; Shimada T; Seki I J Cardiol; 1990; 20(4):889-96. PubMed ID: 2151949 [TBL] [Abstract][Full Text] [Related]
14. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy. Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096 [TBL] [Abstract][Full Text] [Related]
15. Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation. Motz W; Strauer BE J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S34-8. PubMed ID: 7533225 [TBL] [Abstract][Full Text] [Related]
16. [Diagnostic and therapeutic problems in hypertensive heart disease]. Strauer BE Z Kardiol; 1993; 82 Suppl 4():17-24. PubMed ID: 8147058 [TBL] [Abstract][Full Text] [Related]
17. Organ protection: benefit from antihypertensive treatment? Motz W; Strauer BE J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S50-4. PubMed ID: 7898094 [TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease. Strauer BE Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004 [TBL] [Abstract][Full Text] [Related]
19. Inter-relationships between hypertension, left ventricular hypertrophy and coronary heart disease. Devereux RB; Roman MJ J Hypertens Suppl; 1993 Jun; 11(4):S3-9. PubMed ID: 8377033 [TBL] [Abstract][Full Text] [Related]
20. [Improvement of coronary reserve following regression of hypertrophy resulting from blood pressure lowering therapy with a beta-receptor blocker]. Motz W; Vogt M; Scheler S; Schwartzkopff B; Strauer BE Dtsch Med Wochenschr; 1993 Apr; 118(15):535-40. PubMed ID: 8472634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]